Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis.

Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis.

Myasthenia gravis (MG) is an autoimmune disease. In recent years, considerable evidence has indicated that Gene Ontology (GO) functions, especially GO-biological processes, have important effects on the mechanisms and treatments of different diseases. However, the roles of GO functions in the pathog...

Full description

Bibliographic Details
Main Authors: Shuang Li, Yuze Cao, Lei Li, Huixue Zhang, Xiaoyu Lu, Chunrui Bo, Xiaotong Kong, Zhaojun Liu, Lixia Chen, Peifang Liu, Yang Jiao, Jianjian Wang, Shangwei Ning, Lihua Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0214857

Internet

https://doi.org/10.1371/journal.pone.0214857

Similar Items